An easy way to remember serum protein electrophoresis for #MedstudentTwitter !
In myeloma, the thumb goes ⤴️ and the pinky finger goes ⤵️
Read 👇🏼 to learn more!
#MedTwitter
We had an excellent Master Class with colleagues from many countries and valuable mentors. I would like to thank EHA for this great opportunity. #EHA#MasterClass#Hematology
A 24-year-old man presented to the hospital because of fever and rapidly progressive hypoxemic respiratory failure. Laboratory evaluation was notable for leukocytosis with bandemia and thrombocytopenia. 2 weeks before presentation, he had been bitten by a mouse.
New guidelines no longer recommend metronidazole as 1st-line CDI therapy. For both mild & severe disease, vancomycin or fidaxomicin are preferred; metronidazole is only recommended if allergy, intolerance, finances preclude use of vanco or fidxomicin ja.ma/34FqY6X
In a world pandemic, with nonstop bad news, a little but beautiful flower of cell therapy for MCL blossomed quietly!
Even on April Fools’ day, this is no joke! This is a most exciting milestone for relapsed #mantlecelllymphoma. This is unprecedented great news for our patients!
Patients with transfusion-dependent β-thalassemia were randomly assigned to receive luspatercept or placebo. During any 12-week period, a greater percentage of patients in the luspatercept group than in the placebo group had a reduction of at least 33%.
"If you hear of an outbreak of plague in a land, do not enter it; but if the plague outbreaks out in a place while you are in it, do not leave that place." newsweek.com/prophet-prayer-…
Ravulizumab has been approved by the FDA for the treatment of atypical hemolytic-uremic syndrome in certain patients. Read more here. ms.spr.ly/6015TT3WV
We spend two-thirds of our lives in our homes. And that's why a research team led by @j_g_allen has identified 36 ways to make our living spaces healthier harvardhealth.social/7f1 via @Harvard